| Product Code: ETC7130554 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of DNA and gene chips to Estonia witnessed significant growth in 2024, with the top exporting countries being Lithuania, Finland, Germany, Sweden, and Poland. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 16.41%, while the growth rate from 2023 to 2024 stood at 8.53%, highlighting a strong upward trend in the market for DNA and gene chip imports in Estonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, 2021 & 2031F |
3.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Industry Life Cycle |
3.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Porter's Five Forces |
3.5 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and genetic testing |
4.2.2 Advancements in genetic research and technology |
4.2.3 Growing prevalence of genetic disorders and diseases |
4.3 Market Restraints |
4.3.1 High cost associated with DNA and gene chip technologies |
4.3.2 Limited awareness and adoption of these technologies in Estonia |
4.3.3 Stringent regulatory and ethical concerns related to genetic testing |
5 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Trends |
6 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Types |
6.1 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Instrumentation, 2021- 2031F |
6.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Oligonucleotide DNA Microarrays (oDNA), 2021- 2031F |
6.2.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Complementary DNA Microarrays (cDNA), 2021- 2031F |
6.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Gene Expression, 2021- 2031F |
6.3.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Cancer Diagnosticsand Treatments, 2021- 2031F |
6.3.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.3.5 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Genetics, 2021- 2031F |
6.3.6 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By SNP Analysis, 2021- 2031F |
6.3.7 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Screening and Monitoring Of Patient Data DuringClinical Trials, 2021- 2031F |
6.3.8 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2021- 2031F |
6.3.9 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.4.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Biotechnological and Pharmaceutical Companies, 2021- 2031F |
6.4.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
7 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Import-Export Trade Statistics |
7.1 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Export to Major Countries |
7.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Imports from Major Countries |
8 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Key Performance Indicators |
8.1 Research and development investment in genetic testing technologies |
8.2 Number of partnerships and collaborations in the genetic research sector |
8.3 Rate of adoption of genetic testing services by healthcare providers and patients |
9 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Opportunity Assessment |
9.1 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Competitive Landscape |
10.1 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenue Share, By Companies, 2024 |
10.2 Estonia Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |